Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Medofed 30mg/1.25mg per 5ml oral solution.
Pharmaceutical Form |
---|
Oral solution. Clear, yellow, flavoured solution for oral administration. |
Each 5ml of solution contains 30mg pseudoephedrine hydrochloride and 1.25 mg triprolidine hydrochloride.
Excipients with known effect: sucrose, methyl para-hydroxybenzoate, tartrazine yellow lake.
Each 5ml of oral solution contain 3500mg sucrose, 5mg methyl para-hydroxybenzoate and 0.08mg tartrazine yellow lake.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Pseudoephedrine |
Pseudoephedrine is a sympathomimetic agent with direct and indirect effects on adrenergic receptors. It has alpha and beta adrenergic activity and some stimulant effect on the central nervous system. The sympathomimetic effect of pseudoephedrine produces vasoconstriction which in turn relieves nasal congestion. |
List of Excipients |
---|
Sucrose |
Amber glass bottles having metal roll on closures or plastic screw caps. Each cap type pilar proof lined with atoxic polyvinyl chloride liner.
Bottles containing either 100 ml or 150 ml or 200 ml of Medofed are available. Measuring spoon is provided inside the carton box.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
19978
Date of first authorisation: 20/12/2005
Date of renewal authorisation: 30/07/2013
Drug | Countries | |
---|---|---|
MEDOFED | Cyprus, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.